260 related articles for article (PubMed ID: 32669100)
1. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.
He X; Chai P; Li F; Zhang L; Zhou C; Yuan X; Li Y; Yang J; Luo Y; Ge S; Zhang H; Jia R; Fan X
Mol Cancer; 2020 Jul; 19(1):115. PubMed ID: 32669100
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis.
Song J; Zhang Z
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080033
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p.
Zhang T; Yang J; Gong F; Li L; Li A
Cell Cycle; 2020 Sep; 19(18):2270-2280. PubMed ID: 32772636
[TBL] [Abstract][Full Text] [Related]
4. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
Huang Y; Xue B; Pan J; Shen N
Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.
Zhao W; Wang S; Qin T; Wang W
J Cell Biochem; 2020 Jul; 121(7):3516-3525. PubMed ID: 32065448
[TBL] [Abstract][Full Text] [Related]
6. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
7. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.
Ni H; Chai P; Yu J; Xing Y; Wang S; Fan J; Ge S; Wang Y; Jia R; Fan X
Cell Death Dis; 2020 May; 11(5):306. PubMed ID: 32366932
[TBL] [Abstract][Full Text] [Related]
9. LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR‑27b in endometrial carcinoma.
Fan L; Wang C; Zhan P; Liu Y
J Ovarian Res; 2023 Jul; 16(1):147. PubMed ID: 37501162
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Wang H; Wang L; Zhang S; Xu Z; Zhang G
Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
[TBL] [Abstract][Full Text] [Related]
12. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
[TBL] [Abstract][Full Text] [Related]
13. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
Liu Y; Li L; Shang P; Song X
Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis-activation and the consequent initiation of Rho GTPase-mediated signaling.
Hu X; Xiang L; He D; Zhu R; Fang J; Wang Z; Cao K
Clin Sci (Lond); 2021 Feb; 135(3):555-574. PubMed ID: 33480975
[TBL] [Abstract][Full Text] [Related]
17. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
Li X; Han X; Yang J; Sun J; Wei P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
19. Rb knockdown accelerates bladder cancer progression through E2F3 activation.
Wang JP; Jiao Y; Wang CY; Xu ZB; Zhang B
Int J Oncol; 2017 Jan; 50(1):149-160. PubMed ID: 27922689
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]